IM-1021

· Immunome, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IM-1021, covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of IM-1021 in Participants With Advanced Cancer [Phase 1]